Grove Collaborative at Emerging Growth Conference 97: turnaround gains traction

Grove Collaborative, a health and wellness-focused direct-to-consumer retail company, presented its turnaround story at the Emerging Growth Conference 97. The company highlighted its shift from heavy losses to positive adjusted EBITDA, positioning itself against Amazon through trust, curation, and ingredient standards rather than speed and price.

Grove reported over 5 million customers and $11 million in cash on hand. CEO Jeff Yurcisin emphasized the company's focus on trust and product curation over delivery speed or broad selection, asserting that "D2C is not dead" and that Amazon has vulnerabilities. Grove's core advantage lies in its "trust and curation" approach, targeting customers concerned about ingredients, microplastics, and environmental impact.

The company has banned more than 2,000 ingredients and uses a rigorous screening process with a science board and chief medical officer. Grove's market capitalization is $45.26 million, and shares have declined 22.46% over the past year. Despite a 14.25% year-over-year revenue decline, the company reported three consecutive quarters of positive adjusted EBITDA.

Management expects human health and wellness messaging to become more prominent into 2027, and Grove's survey data shows 94% of customers trust the company more than Amazon for safe, healthy product curation.